Tirzepatide vs Mounjaro vs Wegovy: Generic vs Brand Explained

One molecule, several names. This is the cleanest way to think about the brand-versus-generic landscape in the UK.

Tirzepatide

The generic chemical name for the dual GLP-1/GIP agonist. Research-grade tirzepatide in the UK is supplied as lyophilised powder for reconstitution.

Mounjaro

The pharmaceutical brand name for tirzepatide marketed for type-2 diabetes. The active molecule is identical to research-grade tirzepatide; the delivery format (pre-filled pen) and licensing are different.

Zepbound / Mounjaro for weight loss

Same molecule again, marketed under a different brand for obesity indications in some territories.

Wegovy

Different molecule. Wegovy is high-dose semaglutide, a GLP-1-only agonist. See our dose-equivalence chart.

Why this matters for research

Research-grade tirzepatide gives you the same molecule for a fraction of the brand price, with control over dose, BAC water volume and titration timing.

Frequently asked questions

Is generic tirzepatide as good as Mounjaro?

The molecule is identical. The difference is licensing and delivery format.

Why is Wegovy weaker than tirzepatide?

Wegovy is semaglutide — single-receptor. Tirzepatide is dual-receptor.

Can I switch from Wegovy to tirzepatide?

Researchers do. See our dose conversion chart.

This guide is provided for informational purposes by Next Day Pharma. All peptides supplied are FOR RECONSTITUTION. Always consult a qualified healthcare professional before use.